Wednesday, May 31, 2006

Bangalore Bio from June 7

Bangalore Bio from June 7

The Hindu

Over 500 delegates to attend three-day event

# The theme of the conference this year is `Discover, Nurture, Accelerate'
# Young researchers, scientists and technocrats to present papers on path-breaking ideas and innovative research

Bangalore: The Bangalore Bio 2006 conference will set a new direction for the emerging biotechnology industry with more than 60 international and national speakers and over 500 delegates from industry, academia, research and development and policy makers set to take part in the sixth edition of the event, which begins on June 7. The theme of the conference this year is "Discover, Nurture, Accelerate."

Anup K. Pujari, Principal Secretary to Government, Department of IT, Biotechnology and Science & Technology, said: "The conference will offer a strategic view to the swiftly growing biotechnology industry at a global and regional level."

During the three-day event, eminent speakers will discuss various issues such as clinical development in India; transnational research: the way forward for drug discovery; creating an investment landscape for Indian biotechnology; vaccines: an R&D focus for the developing world; global networks in biotechnology; frontier technologies: sowing the seeds for tomorrow and Intellectual Property: a time for self-regulation.

The conference will showcase and bring together, for the first time, 50 young researchers, scientists and technocrats to present their papers on path-breaking ideas and innovative research in various areas of biotechnology at the "Poster Session for Leader Prospects" being held concurrently in Bangalore Bio 2006 under the title "Walkway of Discovery."

Collaboration

"The main goal of this session is to foster top-notch collaborations among academia, research organisations, venture capitalists and industry. It will offer an audience of over 1,000 industry professionals, who are actively looking for technology innovations and collaborations with academia and early stage research organizations. This space is certainly a look out for CEOs, venture capitalists, heads of companies and research labs and institutes for the path breaking attempts and commercial potential of the abstracts," said K.K. Narayanan President, ABLE, & Managing Director, Metahelix

0 Comments:

Post a Comment

<< Home